The latest news from the UW Health Sciences and UW Medicine: What price for a cure? The economics of drug pricing The uproar against the $1,000-a-pill hepatitis C drug Sovaldi, generic name sofosbuvir, may signal a turning point in drug pricing in the United States. Purchasers appear to be pushing back and saying, “No.”
The official announcement of the results of the National Residency Matching Program is an annual rite of passage for UW medical students and their peers across the United States. The wait is over.
People who are genetically equipped to stop hepatitis C viruses from turning off a type of interferon generally have a robust antiviral response. Findings on the mechanisms governing this ability suggest new avenues for treatment research.
A fossil-free method of sequencing archaic DNA may provide insight into human evolution.
The national, decade-long ACTIVE study showed that cognitive training can help the elderly maintain certain thinking and reasoning skills useful in everyday life.
Clark was recognized for his work in the neurobiology of motivated behavior. His award will support investigations of how alcohol exposure during the teen years might lead to chronic alcoholism in adults.
Cell surface lipids hide molecular patterns that infection-killing cells might recognize as dangerous.
Filtered from a vast sodium sea, more than 1 million calcium ions per second gush through our cells’ pores to generate charges
Rapamycin, an anti-rejection drug for organ transplant patients, has now been shown to increases survival in and delayed symptoms of Leigh’s syndrome. The drug appears to cause a metabolic switch that bypasses the mitochondrial deficiency.
The method may help overcome a major obstacle that has delayed progress in designing rapid, low-cost — but still accurate — ways to assemble genomes from scratch. It also may validate certain types of chromosomal abnormalities in cancer.« Previous Page Next Page »